Clinical Trials on Parathyroid Hyperplasia

Total 2070 results

Boehringer Ingelheim

Completed

Real World Data on Management of Male LUTS

Benign Prostatic Hyperplasia

United States
Zhujiang Hospital
The First Affiliated Hospital of Anhui Medical University; The First Affiliated... and other collaborators

Unknown

Transurethral Plasmakinetic Enucleation of Prostate Versus Transurethral Resection of Prostate (ERP)

Benign Prostatic Hyperplasia

China
Saint-Joseph University

Completed

A Pumpkin Seed, Isoflavonoid and Cranberry Mix in LUTS/BPH

Benign Prostatic Hyperplasia

Lebanon
Bangabandhu Sheikh Mujib Medical University, Dhaka...

Completed

Efficacy of Silodosin in the Treatment of Symptomatic Benign Prostatic Hyperplasia (BPH)

Benign Prostatic Hyperplasia

Bangladesh
Allergan

Completed

Safety and Efficacy of Botulinum Toxin Type A to Treat Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

France, Poland, Korea, Republic of, Canada, United States, Germany, Philippines, Czechia
Zenflow, Inc.

Unknown

The Zenflow Spring System Feasibility and Safety Study (ZEST)

Benign Prostatic Hyperplasia

Bulgaria, New Zealand
Sophiris Bio Corp

Completed

Transperineal Intraprostatic Injection of PRX302 Under Ultrasound Guidance for Management of Prostatic Hyperplasia (TRIUMPH-1)

Benign Prostatic Hyperplasia

Canada
NeoTract, Inc.

Completed

The Safety and Effectiveness of UroLift: LIFT Pivotal Study (LIFT)

Benign Prostatic Hyperplasia

United States, Australia, Canada
IRCCS San Raffaele

Unknown

Outcomes and Complications of Holmium Laser Enucleation of the Prostate in Expert Hands (ExpHo)

Benign Prostatic Hyperplasia

Italy
JW Pharmaceutical

Completed

Observational Study to Evaluate Effect of Thrupas® Capsule on Cardiovascular System (CV)

Benign Prostatic Hyperplasia

Korea, Republic of
NeoTract, Inc.

Completed

BPH-6: Comparison of the UroLift System to TURP for Benign Prostatic Hyperplasia (BPH-6)

Benign Prostatic Hyperplasia

Denmark, United Kingdom, Germany
PROCEPT BioRobotics

Completed

AQUABEAM India Study for the Treatment of Benign Prostatic Hyperplasia (ABS)

Benign Prostatic Hyperplasia

India
University of Alberta
Merck Frosst Canada Ltd.

Withdrawn

On Label, Randomized, Double-Blind, Placebo-Controlled Trial of Preoperative Finasteride in Patients Undergoing Transurethral Resection of the Prostate (TURP)

Benign Prostatic Hyperplasia

Canada
Chong Kun Dang Pharmaceutical

Completed

Clinical Trial To Evaluate the Efficacy and Safety of CKD-397 in Benign Prostatic Hyperplasia Patients

Benign Prostatic Hyperplasia

Korea, Republic of
Eli Lilly and Company
Nippon Shinyaku Co., Ltd.

Completed

A Study of Tadalafil (LY450190) in Participants With Lower Urinary Tract Symptoms (LUTS) Suggestive of Benign Prostatic Hyperplasia LUTS (BPH-LUTS).

Benign Prostatic Hyperplasia

Japan
Beni-Suef University

Completed

Effect of 50 and 100 IU Doses of Botox A Toxin Injection in BPH Patients.

Benign Prostatic Hyperplasia

Egypt
Shiraz University of Medical Sciences

Completed

Evaluation of Finastride Effect in Different Dosage on the Amount of Perioperative Bleeding in Transurthral Resection of Prostate (TURP)

Benign Prostate Hyperplasia

Iran, Islamic Republic of
University Hospital, Rouen

Terminated

Results of Selective Prostatic Arterial Embolization in Patients With Indwelling Urinary Catheter Due to Benign Prostatic Hyperplasia Refractory to Medical Treatment. (Prost-EMBOL)

Benign Prostatic Hyperplasia

France
Assistance Publique - Hôpitaux de Paris

Completed

QUAPELLA (QUAlity of Prostate Enucleation by LUMENIS - Laser) (QUAPELLA)

Benign Prostatic Hyperplasia

France
Nymox Corporation

Completed

Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)

Benign Prostatic Hyperplasia

United States
Diskapi Yildirim Beyazit Education and Research...

Unknown

Low Dose Bupivacaine Spinal for Trans Uretral Prostatectomy. (TURP)

Benign Prostate Hyperplasia

Turkey
Diskapi Teaching and Research Hospital

Completed

Addition of Lidocaine to Levobupivacaine Reduces Intrathecal Block Duration

Benign Prostate Hyperplasia

Turkey
Allergan

Completed

Safety and Efficacy Study of Botulinum Toxin Type A to Treat Lower Urinary Symptoms Due to Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

United Kingdom, Taiwan, Korea, Republic of, Canada, Slovakia, France, Italy, Austria, Czech Republic, Australia, Germany
QLT Inc.

Completed

Dose Escalation Study With QLT0074 for Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

United States, Canada
Samsung Medical Center

Unknown

Effects of Tamsulosin 0.4mg on Clinical Outcomes in Korean Men With Severe Symptomatic Benign Prostatic Hyperplasia (BPH)

Benign Prostatic Hyperplasia
Eli Lilly and Company

Completed

Pilot Study Investigating Safety and Efficacy of Tadalafil as Treatment for Benign Prostatic Hyperplasia (BPH) in Asian Men

Benign Prostatic Hyperplasia

Korea, Republic of
Sanofi

Completed

Long Term Safety of SL77.0499-10 (Alfuzosin) in Patients With BPH

Benign Prostatic Hyperplasia

Japan
Assistance Publique - Hôpitaux de Paris

Completed

Procedure Transurethral Needle Ablation (TUNA) and Hospitalization of Short Duration (EPURE)

Benign Prostatic Hyperplasia

France
Eli Lilly and Company
ICOS Corporation

Completed

Effects of Tadalafil Once a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

United States, Greece, Portugal
RECORDATI GROUP

Completed

Evaluation of the Efficacy and Safety of Silodosin in the Treatment of the Signs and Symptoms of BPH

Benign Prostatic Hyperplasia

United Kingdom
Weill Medical College of Cornell University

Completed

A Prospective Evaluation of the GreenLight Model 120 Laser

Benign Prostatic Hyperplasia

United States
Hospices Civils de Lyon

Unknown

Kinetics of the Finasteride Prostate Induced Apoptosis

Benign Prostatic Hyperplasia

France
Yonsei University

Completed

The Effective Concentration of Lidocaine With Fentanyl in Lumbar Epidural Anesthesia for Transurethral Resection of Prostate(TURP) in Elderly Patients

BPH( Benign Prostate Hyperplasia) | TURP(Transurethral Resection of Prostate)

Korea, Republic of
Amgen

Completed

A Study of an Investigational Medication for Severe Primary Hyperparathyroidism or Parathyroid Cancer

Hyperparathyroidism | Parathyroid Neoplasms
Medi-Tate Ltd.

Completed

Study to Assess the Efficacy of Medi-Tate iTind Device

Benign Prostatic Hyperplasia (BPH)

Spain, Belgium, Italy, Switzerland, United Kingdom
GemVax & Kael

Completed

A Phase II Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Patients With BPH

Benign Prostatic Hyperplasia (BPH)

Korea, Republic of
University of Kansas Medical Center

Enrolling by invitation

SOLTIVE™ Laser Enucleation for Treatment of Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia | BPH

United States
Dongkook Pharmaceutical Co., Ltd.

Completed

Safety and Pharmacokinetic Characteristics of DKF-313

Healthy | Benign Prostate Hyperplasia

Korea, Republic of
Eli Lilly and Company

Terminated

A Study in Men With Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

United States, Germany, France, Australia, Greece, Canada, Russian Federation, Italy
Brooklyn Urology Research Group
American Medical Systems; Richard Wolf Medical Instruments Corporation (RWMIC)

Completed

Phase 4 Study of Greenlight XPS Laser Versus BiVAP Saline Vaporization of the Prostate in Men With Symptomatic Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia (BPH)

United States
Daniel Stephan Engeler

Completed

A Prospective Investigation Using the Expired Breath Ethanol Test

Benign Prostatic Hyperplasia (BPH)

Switzerland
HistoSonics, Inc.

Withdrawn

Safety and Initial Efficacy Study of the Vortx Rx for Treatment of Benign Prostatic Hyperplasia (Canada)

Benign Prostatic Hyperplasia (BPH)
Royal Victoria Hospital, Canada
McGill University

Completed

Holmium Laser Enucleation of Prostate(HOLEP) vs Greenlight(XPS) Laser Photoselective Vapo-Enucleation of Prostate(PVEP)

Benign Prostate Hyperplasia

Canada
Samsung Medical Center
The Korean Urological Association

Withdrawn

The Clinical Efficacy of Non-steroidal Anti-inflammation Drugs in Patients With Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

Korea, Republic of
Watson Pharmaceuticals

Completed

A New Drug for Benign Prostatic Hyperplasia (BPH) Compared With Placebo

Benign Prostatic Hyperplasia (BPH)

United States
Kissei Pharmaceutical Co., Ltd.

Completed

A Comparative Study of KSO-0400 in BPH Patients With LUTS

Benign Prostatic Hyperplasia (BPH)

Japan
Lawson Health Research Institute
Gyrus ACMI, Inc.

Completed

Bipolar vs Monopolar Transurethral Resection of the Prostate (TURP)

Benign Prostatic Hyperplasia | BPH

Canada
Benha University

Completed

The Effect of Pre-operative Use of Finasteride Versus Cyproterone Acetate on Blood Loss With Transurethral Resection of Prostate

Prostate Hyperplasia

Egypt
Trio Medicines Ltd.

Completed

Effect of Netazepide on Omeprazole-induced Changes in Chromogranin A and Gastrin

Dyspepsia | ECL-cell Hyperplasia | Parietal-cell Hyperplasia | Rebound Hyperacidity
Fondazione Policlinico Universitario Agostino Gemelli...

Recruiting

European Multicentric Study on Parathyroid Carcinoma (EMS-PC)

Parathyroid Carcinoma

Italy

Clinical Trials on Parathyroid Hyperplasia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Paraguay

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations